• Phoenix Supercomputer Gateway to Personalized Medicine

    Jan 30, 2012, 12:35 PM by Michael Croft
    Arizona Republic | A massive building near Phoenix Sky Harbor International Airport -- the CSS Institute -- is now home to a supercomputer that one day is expected to store clinical-research reports, medical records and the decoded genetic makeup of millions of patients and their cancers.
    Full story

  • What is (Quantitative) Systems Pharmacology?

    Jan 30, 2012, 01:00 AM by Michael Croft
    Bio-IT World | Last October, Harvard Medical School announced a broad initiative in systems pharmacology while the NIH released a like-minded white paper on quantitative and systems pharmacology in the post-genomic era. That's a fair amount of attention from two very big guns on a topic that may ring both familiar and unfamiliar.
    Full story

  • Branding Academic Publishers 'Enemies of Science' is Offensive

    Jan 27, 2012, 08:45 AM by Michael Croft
    The Guardian | Noting that scientific publishers "are not philanthropists, charities or funding agencies," a member of the industry pens a rebuttal to recent staunch criticism that academic publishers are "anti-science" and "anti-publication" in light of the proposed US Research Works Act.
    Full story

  • Accelrys' Cheminformatics Solution in HEOS Cloud

    Jan 26, 2012, 09:30 AM by Michael Croft
    Bio-IT World | The Accelrys next-generation informatics suite consists of updated existing products and components, but perhaps most noteworthy is the marriage with a cloud-based product called HEOS, in partnership with Scynexis, for externalizing research. 
    Full story

  • UK Scientists Call For National DNA Database for Personalized Medicine

    Jan 26, 2012, 08:40 AM by Michael Croft
    Daily Telegraph | In a report to the UK government, a group of UK scientists argues that a national DNA database is needed if the National Health Service is to capitalise on advances in technology and offer personalised genomic medicine to all in the future.
    Full story

  • Bush Doctrine: The Pharmaceutical Safety Data Problem

    Jan 25, 2012, 14:30 PM by Michael Croft
    Bio-IT World | The Bush Doctrine: What the industry calls “safety data” covers everything from discovery-oriented in vitro or cell based studies to extensive GLP toxicology study data, voluminous clinical study records, and post-marketing/pharmacovigilance systems. It leads one to wonder: does anyone have informatics systems that allow safety investigators across the pharma enterprise to effectively mine this ocean of information? 
    Full story

  • Roche Launches Hostile Bid for Illumina to Reclaim Next-Gen Sequencing Mantle

    Jan 25, 2012, 09:00 AM by Michael Croft
    New York Times | Roche, the Swiss drug maker, has launched a $5.7 billion hostile bid for Illumina, going directly to the company’s shareholders. In early trading, Illumina shares soared some 40%, trading above the $44.50 Roche was willing to offer.
    Full story

  • Good Days and Bad in 2011

    Jan 24, 2012, 08:45 AM by Michael Croft
    Bio-IT World | Physicists seem to be having all the fun right now -- monster black holes, inhabitable planets, glimpses of God particles and hearty challenges to Einstein. But a list of last year's top ten science stories in the Guardian found room for only a couple of items in contemporary biology. 
    Full story

  • Children’s Hospital Launches CLARITY Challenge for Clinical Genome Interpretation

    Jan 23, 2012, 15:40 PM by Michael Croft
    Bio-IT World | Researchers at Children’s Hospital in Boston have launched the $25,000 CLARITY Challenge, to develop standards and best practices for clinical genomic analysis and interpretation. Project co-founder Isaac Kohane says an open contest is the best way to catalyze "a public and transparent improvement of that pipeline." 
    Full story

  • Remedies for Safer Drugs

    Jan 23, 2012, 10:00 AM by Michael Croft
    Bio-IT World | Pharmacovigilance experts have an abundance of signal detection tools to sift through large quantities of data seeking causal relationships between adverse events (AEs) and experimental drugs. They also have an assortment of data mining tools capable of finding statistical associations suggestive of problems regarding approved drugs. All this technology is intended to safeguard clinical trial participants, patients, and the reputation of recall-weary drug developers. But drug safety specialists can’t be sure which technology or signal detection method is best.
    Full story

  • Flu Researchers Voluntarily Pause

    Jan 20, 2012, 16:45 PM by Michael Croft
    Bio-IT World | A group of researchers working on the H5N1 avian flu virus have agreed to a 60-day moratorium on research "to allow time for international discussion." The agreement was published in Science and Nature on Friday via a letter from 39 researchers.
    Full story

  • Fostering Innovation at Sanofi

    Jan 20, 2012, 05:45 AM by Michael Croft
    Xconomy | Chris Viehbacher, CEO of Sanofi, is focusing on building innovation thanks to last year's acquisition of Genzyme and academic and biotech collaborators.
    Full story

  • Blind Computing with Quantum Physics

    Jan 20, 2012, 05:20 AM by Michael Croft

    BBC | Computing with quantum physics could carry out fast, complex computations and even increase security in the cloud. "Blind quantum computing" can even be carried out without a cloud computer ever knowing what the data is.

     

    Full story

  • Medidata: Integrating Infrastructure for Clinical Trials

    Jan 18, 2012, 07:10 AM by Michael Croft
    Bio-IT World | Glen de Vries thought he would be teaching biology or chemistry in college, but somewhere en route to a satisfying career in academic research, he got distracted. Bio•IT World chief editor Kevin Davies spoke to de Vries about the progress of Medidata and the state of e-clinical technology in general. 

      

    Full story

  • Academic Publishers Have Become the Enemies of Science

    Jan 17, 2012, 11:30 AM by Michael Croft
    The Guardian | British academic Mike Taylor assails the Research Works Act (RWA), introduced in the US Congress last month, which amounts to a declaration of war by for-profit scientific publishers. the result would be "an ethical disaster: preventable deaths in developing countries, and an incalculable loss for science in the USA and worldwide."
    Full story

  • Cracking Open the Scientific Process

    Jan 17, 2012, 09:50 AM by Michael Croft
    New York Times | Social networking sites such as Berlin-based ResearchGate and meetings liks this weeks ScienceOnline conference in North Carolina are helping to crack open the scientific process.
    Full story

  • A Business Reporter's Personal Genome Journey

    Jan 17, 2012, 08:00 AM by Michael Croft
    Bloomberg | John Lauerman, a healthy 50-something reporter for Bloomberg, offers a first-person account of his recent decision to enroll in George Church's Personal Genome Project.
    Full story

  • A QuantuMDx Leap for Handheld DNA Sequencing

    Jan 17, 2012, 00:00 AM by Michael Croft
    Bio-IT World | Speaking for the first time in his life as a commercial consultant rather than a public servant, Sir John Burn, a highly respected clinical geneticist in the United Kingdom, provided the first glimpse at a nanowire technology for rapid DNA genotyping that could eventually mature into the world’s first handheld DNA sequencer.
    Full story

  • Scientists Offer The Edge Their Most Beautiful Explanations

    Jan 16, 2012, 01:05 AM by Michael Croft
    The Edge | A stunning assembly of almost 200 scientists and artists -- including the likes of Richard Dawkins, George Church, Nathan Myhrvold, Brian Eno and Alan Alda -- answer The Edge.org's Question of the Year: 'What is your favorite deep, elegant, or beautiful explanation?'
    Full story

  • Health Care's X-Prize

    Jan 13, 2012, 06:45 AM by Michael Croft
    The Guardian | The X-Prize has launched a new competition with a $10m prize to be the first to [re?] invent Dr. Spock's tricorder. The Tricorder Qualcomm X-Prize, co-funded by Qualcomm and the X-Prize Foundation, is named for the instant-diagnosis gadget from Star Trek. The competition's goal is a consumer-friendly product that will diagnose 15 common conditions.
    Full story